🔗 IDA SENTENCE ANALYSIS

台大口腔顎面外科主任李正今天受訪時表示 — sentence-by-sentence verification

喨粒晶牙醫診所　·　Source page www.shining-dc.com.tw/拔完牙傷口爛露骨-骨鬆藥物釀禍 ↗　·　c　·　3 statements verified　·　← Back to analysis index

Provable

Partly supported

Pending

Contradicted

What this page measures: whether each outward-facing statement on this article can be supported by dental research literature. Provable and partly-supported statements carry real PubMed references; pending and contradicted ones are marked only as "examined but insufficient / counter-evidence found", with no claim of support. The analysed content itself lives on source page ↗.

🔗 Sentence-by-sentence analysis (3 statements)

DNT-96DEC79A20E1

拔完牙傷口爛露骨骨鬆藥物釀禍 - 台中喨粒晶牙醫診所 Skip to content 診療項目人工植牙 All on 6及舒眠牙醫牙周病治療與水雷射牙齒美白全瓷冠齒列矯正兒童牙科顯微輔助及止鼾門診隱形牙套專家｜3D 數位隱適美透明矯正醫師介紹最新消息衛教知識牙周病會傳染，唾液竟是罪魁禍首！

○ Pending (insufficient evidence; no claim of support)

10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過；不得以檢索相似度或主題重疊升為可證明。

DNT-754B9E10655E

台大口腔顎面外科主任李正今天受訪時表示，患者使用的藥物「雙磷酸鹽類藥物」（Bisphosphonate），多半是有骨質疏鬆、癌症骨轉移患者用來「保骨本」的藥物，不過，近年卻發現部分患者服藥後，一旦有拔牙、植牙傷口，特別容易受感染，輕則鼻竇炎、蜂窩性組織炎，嚴重恐致下顎骨壞死，曾遇過患者骨肉爛到下巴破個洞，吃個飯都會「漏出來」，得整塊切除重建。

◐ Partly supported (scope noted below)

Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.The Tohoku journal of experimental medicine · 2019 · PMID 30713280

Supported scope: 雙磷酸鹽類藥物用於骨質疏鬆或癌症骨轉移患者的骨吸收抑制治療；拔牙、植牙等侵襲性處置列為 ARONJ 風險因子

DNT-775F5402ED8B

李正提出3點呼籲，骨鬆、骨癌等處方醫師一定要告知患者藥物風險，患者看牙醫時也得告知牙醫師有在服用這種藥物，牙醫師治療時應特別注意患者口腔保健，減少拔牙機會，並隨時檢查有無骨壞死跡象，及早治療以防惡化。

○ Pending (insufficient evidence; no claim of support)

10 candidate paper(s) examined; evidence insufficient to support this statement; still needed: 決定性 gate 未通過；不得以檢索相似度或主題重疊升為可證明。